Search - tctmd.com

Displaying 1 - 20 of 87

Sort: Relevancy | Date

News Daily News

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

Michael O'Riordan

December 11, 2025

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Daily News

Pressure-Based Physiological Testing Results Diverge Between LAD, LCx

Caitlin E. Cox

May 29, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News ACC 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

Caitlin E. Cox

March 31, 2025

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Caitlin E. Cox

May 20, 2024

News Conference News EuroPCR 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Caitlin E. Cox

May 14, 2024

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

Presentation ACC 2023

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Presenter: Annapoorna S. Kini

March 06, 2023

News Daily News

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

Todd Neale

December 02, 2022

News Conference News ESC 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

Todd Neale

August 29, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

Advertisement

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Pressure-Based Physiological Testing Results Diverge Between LAD, LCx

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

With ANOCA, Better to Test Coronary Function in Multiple Vessels

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content